Status:
WITHDRAWN
Functional and Molecular Characterization of Treatment Response in Tumors in the Oral Cavity Using Optical Spectroscopy
Lead Sponsor:
University of Arkansas
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this pilot study is to estimate the sensitivity and specificity of diffuse reflectance spectroscopy (DRS) and Raman spectroscopy (RS) at detecting treatment-resistant disease when DRS...
Detailed Description
The objective of this pilot study is to estimate the sensitivity and specificity of diffuse reflectance spectroscopy (DRS) and Raman spectroscopy (RS) at detecting treatment-resistant disease when DRS...
Eligibility Criteria
Inclusion
- Age 18 years and older
- Diagnosis of stage 3 or 4 HNSCC with documentation of HPV status
- Tumor located in one of the tonsils and/or larynx
- Expected to have ability to tolerate laryngoscope procedure
- Must sign Informed Consent Form
- Scheduled for chemoradiation therapy
Exclusion
- Previous oral cavity or tonsil or pharyngeal surgery or therapy related to the disease
- Disease in both tonsils
- Patients who, in opinion of Investigator, should not participate
- Women who are pregnant or breastfeeding
Key Trial Info
Start Date :
November 22 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 22 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04272294
Start Date
November 22 2024
End Date
November 22 2024
Last Update
November 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States, 72205